FourThought Financial’s Guardant Health GH Stock Holding History

FourThought Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$7K	Sell	135 -7,370	-98%	-$378K	﹤0.01%	1114
2022 Q2	$303K	Buy	7,505 +3,153	+72%	+$156K	0.04%	264
2022 Q1	$288K	Buy	4,352 +1,053	+32%	+$72.1K	0.04%	278
2021 Q4	$330K	Buy	3,299 +2,941	+822%	+$304K	0.04%	259
2021 Q3	$44K	Buy	358 +338	+1,690%	+$40.2K	0.01%	725
2021 Q2	$2K	Buy	20 +5	+33%	+$673	﹤0.01%	1364
2021 Q1	$2K	Sell	15 -5	-25%	-$756	﹤0.01%	1311
2020 Q4	$2K	Buy	+20	New	+$2.3K	﹤0.01%	1292

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FourThought Financial's GH Position: Q3 2022 in Review

FourThought Financial reduced its Guardant Health (GH) stake by 98% in Q3 2022, selling an estimated $378K and leaving 135 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

FourThought Financial first reported a position in GH in Q4 2020 and has held it in 8 quarters since. The position peaked at $330K in Q4 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

FourThought Financial held 135 shares of Guardant Health worth $7K as of Q3 2022.
FourThought Financial sold 7,370 Guardant Health shares in Q3 2022, an estimated $378K.
Guardant Health made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1114 holding.
FourThought Financial first reported a position in Guardant Health in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Guardant Health position peaked at $330K in Q4 2021.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.